Form 4 for AVY Avery Dennison
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01 | AVY | Bondar Lori J | VP, CAO, Ctrlr, Treas | M - OptEx | $170.60 | +7,141 | 29.0K | +33% | +$1.22M |
| DM | 2022-03-03 | 2022-03-01 | AVY | Bondar Lori J | VP, CAO, Ctrlr, Treas | F - Tax | $170.60 | -2,029 | 25.0K | -8% | -$346.1K |
| DM | 2022-03-03 | 2022-03-01 | AVY | Bondar Lori J | VP, CAO, Ctrlr, Treas | M - OptEx | $0.00 | -7,141 | 0 | -100% | $0 |
| DM | 2022-03-03 | 2022-03-01 | AVY | Bondar Lori J | VP, CAO, Ctrlr, Treas | A - Grant | $0.00 | +3,429 | 1,527 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 918 | $170.60 | 24,953.71 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | M | A | 956 | $170.60 | 23,592.71 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-01 | F | D | 251 | $170.60 | 23,341.71 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-01 | M | A | 918 | $170.60 | 24,259.71 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-01 | F | D | 224 | $170.60 | 24,035.71 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-01 | F | D | 1,238 | $170.60 | 27,748.71 | D | — | — | |
| 7 | Common | Common Stock | 2022-03-01 | F | D | 224 | $170.60 | 24,729.71 | D | — | — | |
| 8 | Common | Common Stock | 2022-03-01 | M | A | 377 | $170.60 | 25,106.71 | D | — | — | |
| 9 | Common | Common Stock | 2022-03-01 | F | D | 92 | $170.60 | 25,014.71 | D | — | — | |
| 10 | Common | Common Stock | 2022-03-01 | M | A | 3,972 | $170.60 | 28,986.71 | D | — | — | |
| 11 | Derivative | 2020 MSU Award | 2022-03-01 | M | D | 918 | $0.00 | 973 | D | $0.00 · 2021-02-27 to 2024-03-01 | 918 Common Stock | (F3) Shares reflect the vesting of the second tranche of market-leveraged stock units granted in February 2020 at 183% of target based on our absolute total stockholder return in excess of 10% during the 2020-2021 performance period, plus dividend equivalents accrued during the period. |
| 12 | Derivative | 2022 MSU Award | 2022-03-01 | A | A | 1,902 | $0.00 | 1,902 | D | $0.00 · 2023-03-01 to 2026-03-01 | 1,902 Common Stock | (F6) Market-leveraged stock units vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return, plus dividend equivalents accrued during the vesting period. Each market-leveraged stock unit represents a contingent right to receive one share of our common stock, plus dividend equivalents. |
| 13 | Derivative | 2018 MSU Award | 2022-03-01 | M | D | 956 | $0.00 | 0 | D | $0.00 · 2019-02-22 to 2022-03-01 | 956 Common Stock | (F1) Shares reflect the vesting of the fourth tranche of market-leveraged stock units granted in February 2018 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2018-2021 performance period, plus dividend equivalents accrued during the period. |
| 14 | Derivative | 2019 MSU Award | 2022-03-01 | M | D | 918 | $0.00 | 437 | D | $0.00 · 2020-02-28 to 2023-03-01 | 918 Common Stock | (F2) Shares reflect the vesting of the third tranche of market-leveraged stock units granted in February 2019 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2019-2021 performance period, plus dividend equivalents accrued during the period. |
| 15 | Derivative | 2022 PU Award | 2022-03-01 | A | A | 1,527 | $0.00 | 1,527 | D | $0.00 · 2025-03-01 to 2025-03-01 | 1,527 Common Stock | (F7) Performance units vest, if at all, at the end of fiscal year 2024, provided the designated performance objectives are met as determined by the Compensation Committee in February 2025. Each performance unit represents a contingent right to receive one share of our common stock. |
| 16 | Derivative | 2021 MSU Award | 2022-03-01 | M | D | 377 | $0.00 | 831 | D | $0.00 · 2022-03-01 to 2025-03-01 | 377 Common Stock | (F4) Shares reflect the vesting of the first tranche of market-leveraged stock units granted in February 2021 at 135% of target based on our absolute total stockholder return in excess of 10% during the 2021 performance period, plus dividend equivalents accrued during the period. |
| 17 | Derivative | 2019 PU Award | 2022-03-01 | M | D | 3,972 | $0.00 | 0 | D | $0.00 · 2022-02-28 to 2022-03-01 | 3,972 Common Stock | (F5) Shares reflect the vesting of performance units granted in February 2019 at 188% of target, based 50% on our cumulative economic value added and 50% on our relative stockholder return. |